Clinical Trials on Short Bowel Syndrome in United States

Total 15538 results

Marathon Pharmaceuticals, LLC

Withdrawn

A Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Investigational Product MP-101 in Subjects With Short Bowel Syndrome Who Have Had an Inadequate Response to Anti-Diarrheals

Short Bowel Syndrome | Short Gut Syndrome | SBS | Short Gut | Short Bowel

United States
Shire

Recruiting

A Survey to Assess Participants' and Physicians' Knowledge, Attitudes and Behavior When Using GATTEX (GATTEX KAB)

Short Bowel Syndrome (SBS)

United States
Marathon Pharmaceuticals, LLC

Withdrawn

A Open Label Extension Study for Subjects That Complete Study MP-101-CL-001

Short Bowel Syndrome | Short Gut Syndrome | SBS | Short Gut

United States
University of Texas Southwestern Medical Center
Children's Hospital of Philadelphia

Enrolling by invitation

Predicting Success With Fiber Food Introduction in Short Bowel Syndrome

Short Gut Syndrome

United States
Children's Hospital of Philadelphia
University of Pennsylvania

Recruiting

Fiber Food Introduction in Pediatric Short Bowel Syndrome

Short Gut Syndrome

United States
University of Miami
QOL Medical, LLC

Recruiting

Functional Sucrase Deficiency in Short Bowel Syndrome Patients With Intestinal Failure

Short Gut Syndrome

United States
Wake Forest University

Completed

Early Supplementation of Enteral Microlipid With and Without Fish Oil in Premature Infants With Enterostomies (EMLFO-2)

Prematurity | Short Bowel Syndrome (SBS) | Necrotizing Enterocolitis (NEC) | Intestine Perforation

United States
University of Nebraska
Eli Lilly and Company

Terminated

Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients With Short Bowel Syndrome (SBS)

Short Bowel Syndrome

United States
Shire
Takeda Development Center Americas, Inc.

Active, not recruiting

Registry for Participants With Short Bowel Syndrome

Short Bowel Syndrome

United States
Mayo Clinic

Completed

Short Bowel Syndrome and Teduglutide Versus Placebo

Short Bowel Syndrome

United States
9 Meters Biopharma, Inc.

Unknown

Proof of Concept Study in Patients With Short Bowel Syndrome

Short Bowel Syndrome

United States
Lindsey Russell, MD
Napo Pharmaceuticals, Inc.

Not yet recruiting

Open-Label Pilot Study With Crofelemer in Patients With Short Bowel Syndrome

Short Bowel Syndrome

United States
Boston Children's Hospital
Entrinsic Bioscience Inc.

Terminated

Amino Acid-based Oral Rehydration Solution in Children With Short Bowel Syndrome

Short Bowel Syndrome

United States
Le Bonheur Children's Hospital
University of Tennessee Health Science Center

Unknown

Pectin Use in Pediatric Intestinal Rehabilitation (PUPI)

Short Bowel Syndrome

United States
Eclipse Regenesis, Inc.

Recruiting

A Feasibility Study to Evaluate Safety & Benefit of Eclipse XL1 System in Adult Patients With SBS

Short Bowel Syndrome

United States
University of Nebraska

Withdrawn

Pharmacokinetics of Citalopram in Patients With Short Bowel Syndrome

Short Bowel Syndrome

United States
Children's Hospital of Philadelphia
AbbVie

Completed

Use of Pancreatic Enzymes in Short Bowel Syndrome (SBS)

Short Bowel Syndrome

United States
Christopher Duggan

Completed

Measurement of Body Composition by Air Displacement Plethysmography in Pediatric Intestinal Failure Patients

Short Bowel Syndrome

United States
Mayo Clinic

Completed

Comparison of Different Oral Rehydration Solutions (ORS)

Short Bowel Syndrome

United States
Emory University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Mechanisms of Adaptation in Human Short Bowel Syndrome

Short Bowel Syndrome

United States
St. Louis University
Epharmix, Inc.

Terminated

Effect of a Short Message Service Intervention on Patients With Short Bowel Syndrome

Short Bowel Syndrome

United States
Arkansas Children's Hospital Research Institute
Baylor College of Medicine; USDA Grand Forks Human Nutrition Research Center

Withdrawn

Fiber Use in Pediatric Short Bowel Syndrome

Short Bowel Syndrome

United States
Children's Hospital of Michigan
Merck Sharp & Dohme LLC; Boston Children's Hospital; William Beaumont Hospitals

Completed

Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome

Short Bowel Syndrome

United States
The University of Texas Health Science Center,...

Completed

Elemental Formula in Neonates Post Small Bowel Resection: Improved Weaning From Total Parenteral Nutrition?

Short Bowel Syndrome

United States
Emory University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Diet/Growth Factor Mechanisms of Gut Adaptation

Short Bowel Syndrome

United States
Entrinsic Bioscience Inc.

Terminated

Effects of an Amino Acid Mixture on Gastrointestinal Function, Inflammation and Fluid Balance: A Pilot Study in Patients With Inflammatory Bowel Disease

Inflammatory Bowel Diseases | Ileostomy - Stoma | Short Bowel Syndrome

United States
Boston Children's Hospital
Takeda

Completed

Pediatric Teduglutide Registry (PTR)

Short Bowel Syndrome

United States
Northwestern University
EMD Serono; Northwestern Memorial Hospital

Completed

rHGH and Intestinal Permeability in Intestinal Failure (rHGH)

Short Bowel Syndrome

United States
Boston Children's Hospital
Alcresta Therapeutics, Inc.

Enrolling by invitation

A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB

Malabsorption | Short Bowel Syndrome

United States
Shire

Completed

A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021 (STEPS3)

Short Bowel Syndrome

United States
Boston Children's Hospital
Alcresta Therapeutics, Inc.

Recruiting

A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB

Malabsorption | Short Bowel Syndrome

United States
University of Michigan

Recruiting

MENDD Tolerance Assessment Study

Short Bowel Syndrome

United States
9 Meters Biopharma, Inc.

Terminated

VIBRANT Study of Vurolenatide in Adult Patients With Short Bowel Syndrome.

Short Bowel Syndrome

United States
Elgan Pharma Ltd.

Terminated

Safety and Efficacy Study in Infant With SBS (GIFT)

Short Bowel Syndrome

United States
Shire

Completed

Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study

Short Bowel Syndrome

United States, United Kingdom
Boston Children's Hospital
GlaxoSmithKline; Harvard University

Withdrawn

Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease

Liver Disease | Short Bowel Syndrome

United States
Shire
Nycomed Germany GmbH

Completed

Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)

Short Bowel Syndrome

Spain, United States, Canada, France, Denmark, Poland, Germany, Italy, United Kingdom
Shire

Completed

Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)

Short Bowel Syndrome

United States, Denmark, France, Canada, Belgium, Netherlands, Poland, United Kingdom
Zealand Pharma

Enrolling by invitation

Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension Trial (EASE SBS 3)

Short Bowel Syndrome

Germany, United States, Belgium, Denmark, France, United Kingdom, Netherlands, Poland
Shire

Completed

A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome

Short Bowel Syndrome

United States, United Kingdom
Zealand Pharma

Completed

Efficacy And Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome (SBS) (EASE SBS 1)

Short Bowel Syndrome

United States, Denmark, Belgium, Germany, France, United Kingdom, Canada, Netherlands, Poland
Hanmi Pharmaceutical Company Limited

Recruiting

Phase 2 Study to Assess the Safety, PK, and PD in SBS-IF Subjects

Short Bowel Syndrome

Belgium, Korea, Republic of, United States, Germany, Denmark, France, Poland
Shire

Completed

Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome

Short Bowel Syndrome

United States, France, Germany, Canada, Netherlands, Poland, Denmark, Belgium, United Kingdom
Shire

Completed

Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS)

Short Bowel Syndrome

United States, Canada, Finland, Italy, United Kingdom, Belgium
Mayo Clinic

Withdrawn

SMOFLipid in Patients Who Are Intralipid Intolerant

Short Bowel Syndrome | Home Parenteral Nutrition

United States
Zealand Pharma

Recruiting

Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS (EASE SBS 2)

Short Bowel Syndrome

United States, France, Belgium, Denmark, United Kingdom, Germany, Canada, Italy, Netherlands, Poland
Shire

Completed

Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition

Short Bowel Syndrome

United States, Canada, Finland, Belgium, Italy, United Kingdom, Germany
VectivBio AG

Active, not recruiting

Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome. (STARS extend)

Short Bowel Syndrome

United States, Belgium, United Kingdom, Korea, Republic of, Japan, Taiwan, Germany, France, Czechia, Hungary, Spain, Italy, Poland, Argentina, Denmark, Israel, Norway, Sweden
Shire
Nycomed

Completed

Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) Subjects (STEPS)

Short Bowel Syndrome

United States, Spain, France, Canada, Netherlands, Denmark, Germany, Italy, Poland, United Kingdom
Imperial College London

Withdrawn

Liraglutide on Decreasing Parenteral Support in Short Bowel Patients (SLIPS) (SLIPS)

Short Bowel Syndrome

United Kingdom

Clinical Trials on Short Bowel Syndrome in United States

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations